“…Compared to traditional drugs, nanomedicines have exhibited several advantages, such as a reduction in adverse events, enhanced capabilities for targeted delivery, and improved biosafety [ 16 ]. Gold nanoclusters (AuNCs) protected by peptides or proteins have shown great potential for therapeutic applications and have become an attractive frontier in nanomedicine due to their supernormal physicochemical and biomedical properties, such as ultrasmall size, atomically precise composition, strong luminescence, tailorable surface chemistry, water-soluble, excellent biocompatibility and intrinsic pharmaceutical activities [ 17 , 18 , 19 , 20 ]. Especially in recent years, the immunoregulatory activity of AuNCs was revealed in tumor immunotherapy and autoimmune disease therapy, including rheumatoid arthritis, psoriasis, and inflammatory bowel disease [ 21 , 22 , 23 , 24 ].…”